Cross-border OTC reforms: No path forward

duncan-wood

When the European Commission and the US Commodity Futures Trading Commission (CFTC) unveiled their July 11 agreement on cross-border regulation of over-the-counter derivatives – A path forward – it seemed precisely what the market needed.

After a year of increasingly tense wrangling about regulatory boundaries, a path was undoubtedly a good thing. And forward seemed the right direction. While it might be pleasant in other contexts to take a path to one side or the other – and while going

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: